Daily Herald13h
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you're getting them
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...
How biochemistry and molecular biology gave the world insulin
Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...
Dr. Roach: Weeding out which ads for diabetes are worth looking at
Dear M.W.: Stevia is a natural extract of the Stevia rebaudiana plant. The raw leaves are not considered safe, but purified ...
Hosted on MSN2h
How High-Fructose Corn Syrup Impacts Your Health
Rumors fly about this common sweetener. Here’s how it really affects weight and health, where you’ll find it, and how to spot it on ingredient labels.
FDA: Patients using diabetes apps can miss critical alerts
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...
Dear Doctor: If an ad reads ‘1 weird trick your doctor doesn’t want you to know about,' you can skip it
Also, if you see an ad advertising “one weird trick your doctor doesn’t want you to know about,” you can safely skip it. Your ...
Medscape1d
FDA Warns About Diabetes Device Smartphone Alert Settings
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
Are smartphone diabetes devices putting lives in danger? US FDA sounds alarm
The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...
Monthly Prescribing Reference1d
FDA: Diabetes Device Alerts May Be Missed Due to Smartphone Settings
Health care providers are urged to inform patients to periodically check their smartphone settings and to confirm that they are able to receive alerts.
COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...